These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 92513)

  • 41. Treatment of recurrent lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): a Southwest Oncology Group Study.
    Weick JK; Jones SE; Haut A; Fisher R; Dixon D
    Cancer Treat Rep; 1981; 65(7-8):611-4. PubMed ID: 6166373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of non-Hodgkin's lymphomas with CHOP-bleo. Experience in 16 patients].
    González Brito G; Marsá Vilá L; Chávez MI; Batista López N; Hernández Nieto L
    Sangre (Barc); 1985; 30(3):367-8. PubMed ID: 2412301
    [No Abstract]   [Full Text] [Related]  

  • 43. [Results of treating lymphomas with high degree of malignancy using COPP, CHOP-Bleo and MEV protocols].
    Płuzańska A; Krykowski E; Robak T; Oliskiewicz W; Polkowska E; Dowgier I; Hyjek E
    Pol Tyg Lek; 1982 Sep; 37(36):1049-53. PubMed ID: 6189105
    [No Abstract]   [Full Text] [Related]  

  • 44. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
    Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
    Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Results of combination chemotherapy of non-Hodgkin's lymphoma.
    Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT
    Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP).
    Skarin AT; Rosenthal DS; Moloney WC; Frei E
    Blood; 1977 May; 49(5):759-70. PubMed ID: 66957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Contribution of anthracyclines in treatment of lymphoproliferative disorders].
    Coiffier B
    Pathol Biol (Paris); 1987 Jan; 35(1):75-8. PubMed ID: 2436132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary colorectal T-cell lymphoma.
    Okada M; Maeda K; Suzumiya J; Hagimoto T; Wakamatsu S; Ohshima K; Kanda M; Sonoda T; Sakamoto A; Tamura K
    J Gastroenterol; 2003; 38(4):376-84. PubMed ID: 12743779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple agent chemotherapy including bleomycin of non-Hodgkin's lymphoma during pregnancy.
    Ortega J
    Cancer; 1977 Dec; 40(6):2829-35. PubMed ID: 73411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma.
    McKelvey EM; Gottlieb JA; Wilson HE; Haut A; Talley RW; Stephens R; Lane M; Gamble JF; Jones SE; Grozea PN; Gutterman J; Coltman C; Moon TE
    Cancer; 1976 Oct; 38(4):1484-93. PubMed ID: 791473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of radiation dose and tumor size on large cell lymphoma patients in complete response after integrated CHOP-Bleo-radiation treatment protocol.
    Earle JD
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):193-4. PubMed ID: 7527797
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical trials with BCNU (NSC-409962) in malignant lymphomas by the Eastern Cooperative Oncology Group.
    Bennett JM; Bakemeier RF; Carbone PP; Ezdinli E; Lenhard RE
    Cancer Treat Rep; 1976 Jun; 60(6):739-45. PubMed ID: 60176
    [No Abstract]   [Full Text] [Related]  

  • 54. Cyclophosphamide, vincristine, and prednisone (CVP) versus adriamycin, bleomycin, and prednisone (ABP) in stage IV non-Hodgkin's lymphomas.
    Monfardini S; Tancini G; DeLena M; Villa E; Valagussa P; Bonadonna G
    Med Pediatr Oncol; 1977; 3(1):67-74. PubMed ID: 65728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group study.
    Jones SE; Grozea PN; Metz EN; Haut A; Stephens RL; Morrison FS; Butler JJ; Byrne GE; Moon TE; Fisher R; Haskins CL; Coltman CA
    Cancer; 1979 Feb; 43(2):417-25. PubMed ID: 84706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemotherapy of the non-Hodgkin's lymphomas.
    Pasmantier MW; Coleman M; Silver RT
    Med Clin North Am; 1976 Sep; 60(5):1043-52. PubMed ID: 59842
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment of malignant lymphomas with shock doses of peptichemio].
    Battelli T; Bonsignori M; Manocchi P
    Minerva Med; 1975 Jun; 66(43):2087-93. PubMed ID: 49865
    [No Abstract]   [Full Text] [Related]  

  • 58. [Computed tomographic and sonographic control of the treatment of non-Hodgkin's lymphoma of the stomach].
    Köster O; Harder T
    Rofo; 1982 Dec; 137(6):727-9. PubMed ID: 6218055
    [No Abstract]   [Full Text] [Related]  

  • 59. Induction chemotherapy of non-Hodgkin's malignant lymphomas. Preliminary results of a controlled trial.
    Chauvergne J; Durand M; Hoerni B; Hoerni-Simon G; Brunet R; Lagarde C
    Eur J Cancer (1965); 1977; 13(4-5):399-400. PubMed ID: 326551
    [No Abstract]   [Full Text] [Related]  

  • 60. [Bilateral highly malignant centroblastic lymphoma of the breast].
    Hering M; Hagel E; Zwicker C; Krieger G
    Rofo; 1996 Aug; 165(2):198-200. PubMed ID: 8924675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.